期刊文献+

雷帕霉素靶向阻断作用对鼻咽癌细胞生长的实验研究 被引量:1

Inhibition of cell growth by rapamycin through targeting mammalian target of rapamycin signaling pathway in nasopharyngeal carcinoma
原文传递
导出
摘要 目的 研究雷帕霉素对鼻咽癌细胞株CNE-1、CNE-2的生长抑制作用及对细胞周期的影响.方法 采用活细胞计数试剂盒法(cellcounting kit-8,CCK-8法)观察不同浓度雷帕霉素在不同时间点对鼻咽癌细胞的生长抑制作用,光学显微镜下观察其形态学变化,流式细胞仪检测其细胞周期变化及细胞凋亡情况,反转录聚合酶链反应分析哺乳动物雷帕霉素靶蛋白基因的表达情况.结果 雷帕霉索在一定浓度范围内对鼻咽癌细胞株CNE-1、CNE-2的生长抑制作用随药物浓度的升高而逐渐增强.光镜下可观察到细胞变圆、密度降低等形态学的改变.流式细胞仪显示,150 nmol/L雷帕霉素作用48 h,CNE-1和CNE-2细胞生长周期均出现G0/G1期阻滞,且变化亦随药物浓度升高而增强;但诱导细胞凋亡作用不明显.反转录聚合酶链反应显示雷帕霉素使CNE-2细胞株哺乳动物雷帕霉素靶蛋白mRNA的表达下降(t=10.625,P<0.01).结论 雷帕霉素对鼻咽癌细胞株CNE-1、CNE-2具有生长抑制作用,可阻滞细胞周期进展,并可能通过下调哺乳动物雷帕霉素靶蛋白的表达而抑制细胞生长和细胞周期. Objective To study the effects of rapamycin on cell growth and cell cycle in CNE-1 and CNE-2 cells. Methods Growth inhibition effect of rapamycin on CNE-1 and CNE-2 cells were assessed by cell counting kit-8 (CCK-8) assay. Morphological alterations of the cells were observed by microscope. Cell cycle and cell apoptosis were analyzed by FCM. The expression of mammalian target of rapamycin (mTOR)was analyzed by reverse transcription-polymerase chain reaction(RT-PCR). Results The growth of CNE-1and CNE-2 cells was inhibited significantly by rapamycin dose-dependently. FCM showed that CNE-1 and CNE-2 cells at 48 hours after rapamycin ( 150 nmoL/L) treatment were arrested in the G0/G1 phase of cell cycle. However rapamycin treatment did not significantly induce apoptosis of CNE-1 and CNE-2 cells (P 〉0. 05). RT-PCR showed that rapamycin significantly inhibited mRNA expression of mTOR in CNE-2 cells (t = 10. 625 ,P 〈 0. 01 ). Conclusions Rapamycin inhibits the growth of CNE-1 and CNE-2 cells by inhibiting the progression of cell cycle, which could be achieved through decreaseing the expression of mTOR.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2010年第9期765-768,共4页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家自然科学基金(30572020) 湖南省科技厅项目(07KS2003,2007SK3050) 湖南省自然科学基金(08JJ5017)
关键词 鼻咽癌 西罗莫司 细胞系 肿瘤 Nasopharyngeal neoplasms Sirolimus Cell line, tumor
  • 相关文献

参考文献13

  • 1Bhatia S,Thompson JA.Temsirolimus in patients with advanced renal cell carcinoma:an overview.Adv Ther,2009,26:55-67.
  • 2Kinkade CW,Castillo-Martin M,Puzio-Kuter A,et al.Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model.J Clin Invest,2008,118:3051-3064.
  • 3Fechner G,Classen K,Schmidt D,et al.Rapamycin inhibits in vitro growth and release of angiogenetic factors in human bladder cancer.Urology,2009,73:665 -669.
  • 4Kopelovich L,Fay JR,Sigman CC,et al.The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention.Cancer Epidemiol Biomarkers Prey,2007,16:1330-1340.
  • 5Albert JM,Kim KW,Cao C,et al.Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer.Mol Cancer Ther,2006,5:1183-1189.
  • 6Amornphimoltham P,Patel V,Sodhi A,et al.Mammalian target of rapamycin,a molecular target in squamous cell carcinomas of the head and neck.Cancer Res,2005,65:9953-9961.
  • 7Fingar DC,Blenis J.Target of rapamycin(TOR):an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.Oncogene,2004,23:3151-3156.
  • 8陈英杰,刘健,陶雅君,贾心善.PTEN、PI3K和mTOR在鼻咽癌中的表达及意义[J].现代肿瘤医学,2009,17(1):41-43. 被引量:8
  • 9Surace EI,Lusis E,Haipek CA,et al.Functional significance of S6K overexpression in meningioma progression.Ann Neurol,2004,56:295-298.
  • 10Caron S,Charon M,Cramer E,et al.Selective modification of eukaryotic initiation factor 4F (eIF4F) at the onset of cell differentiation:recruitment of eIF4G Ⅱ and long-lasting phosphorylation of eIF4E.Mol Cell Biol,2004,24:4920-4928.

二级参考文献8

  • 1刘民锋,罗剑,余险峰,唐启彬,陈勇军,邹声泉.PTEN和mTOR信号转导通路在胆管癌发展中作用的研究[J].中国普通外科杂志,2006,15(4):274-276. 被引量:13
  • 2李平,钟雪云,秦艳芳,林琛莅,贾晋萍.PTEN在人脑胶质瘤细胞中的表达及其对细胞增殖的影响[J].癌症,2007,26(3):247-251. 被引量:7
  • 3Shamji AF, Nghiem, P, Schreiber SI. Intergration of growth factor and nutrient signaling: implications for cancer biology [ J]. Mol Cell,2003,12:271 - 280.
  • 4Zhou X, Tan M, Stone Hawthome V, et al. Activation of zhe Akt/ mTOR/4E -BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers[ J]. Clin Cancer Res ,2004,10:6779 - 6788.
  • 5Asnaghi L, Bruno P, Priulla M, et al. roTOR: a protein kinase switching between life and death[J]. Phamacol Res,2004,50:545 - 549.
  • 6Mark GS, Leigh AB, Megan MK, et al. PTEN induced vascular endothelial growth fator secretion in head and neck squamous cell carcinoma[J].Biochem Biophys Res Commun, 2005,331 : 295 - 302.
  • 7Alvin D, Thompsom Ⅲ, Sham SK. Insulin and PTEN regulate the expression of the pituitary tumor transforming gene in breast tumor cells[ J]. FEBS Lett ,2005,579:3195 - 3200.
  • 8David D, Kyung S. Cross -talk between PTEN and TGF -βsignaling pathways[ J]. Cytokine Growth Fator Rev,2006 ,17 :59 - 74.

共引文献7

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部